Dimensional Fund Advisors’s ARS Pharmaceuticals SPRY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.15M | Sell |
180,492
-7,153
| -4% | -$125K | ﹤0.01% | 2639 |
|
|
2025
Q1 | $2.36M | Sell |
187,645
-8,813
| -4% | -$111K | ﹤0.01% | 2687 |
|
|
2024
Q4 | $2.07M | Buy |
196,458
+4,010
| +2% | +$42.3K | ﹤0.01% | 2777 |
|
|
2024
Q3 | $2.79M | Hold |
192,448
| – | – | ﹤0.01% | 2701 |
|
|
2024
Q2 | $1.64M | Sell |
192,448
-82,841
| -30% | -$705K | ﹤0.01% | 2808 |
|
|
2024
Q1 | $2.81M | Sell |
275,289
-49,437
| -15% | -$505K | ﹤0.01% | 2708 |
|
|
2023
Q4 | $1.78M | Sell |
324,726
-49,012
| -13% | -$269K | ﹤0.01% | 2810 |
|
|
2023
Q3 | $1.41M | Sell |
373,738
-19,912
| -5% | -$75.3K | ﹤0.01% | 2851 |
|
|
2023
Q2 | $2.64M | Buy |
393,650
+59,391
| +18% | +$398K | ﹤0.01% | 2710 |
|
|
2023
Q1 | $2.18M | Buy |
334,259
+166
| +0% | +$1.08K | ﹤0.01% | 2728 |
|
|
2022
Q4 | $2.85K | Buy |
334,093
+3,359
| +1% | +$29 | ﹤0.01% | 2620 |
|
|
2022
Q3 | $1.75M | Buy |
330,734
+266,613
| +416% | +$1.41M | ﹤0.01% | 2750 |
|
|
2022
Q2 | $272K | Buy |
+64,121
| New | +$272K | ﹤0.01% | 3199 |
|